Category: Uncategorized

Viant Technology (DSP) has gotten hammered during this year of its IPO launch (79% drop YTD!), but indicators are suggesting that we may be about to head back up in quick fashion. Number one: this programmatic advertising company is very popular among current and former staff, as Glassdoor.com indicates 92% of those folks would recommend… Continue reading 9Dec21: Viant and CMF

The market bounceback from Omicron had a much shorter lag than the earlier COVID fear-based drops, as reported in the New York Times yesterday. These ups and downs can certainly make one queasy… but like any moment of fluctuation it provides an opportunity to buy in at a low point. These five are currently at… Continue reading 8Dec21: Hot Five

The Dirty Dozen group of securities was created on October 7th and I’ll be tracking its progress on a monthly basis by posting on the 7th of each month. Market cap will be the measurement for gains and losses. Two month returns: Puma Biotech (PBYI) $121M (-53%) Brightcove (BCOV) $401M (-16%) Sierra Wireless (SWIR) $622M… Continue reading 7Dec21: DD Report Mo.2

The legendary brains behind Berkshire Hathaway’s success are Warren Buffett and his second in command Charlie Munger. When these guys speak, it’s worth listening to. Munger yesterday had a video interview at an investor conference and the Australian Business Review printed this quote regarding the current state of the stock market: “Some of the valuations… Continue reading 3Dec21: Munger’s Wisdom

Omicron fear has led to some of the best entry points ever to own particular growth companies. These nine are charged… and ready to surge: Puma Biotech (PUMA) $122M Viant (DSP) $570M Perion (PERI) $840M Vaxart (VXRT) $882M PubMatic (PUBM) $1.88B Magnite (MGNI) $2.22B fuboTV (FUBO) $2.57B DoubleVerify (DV) $4.76B Trade Desk (TTD) $49.7B “No… Continue reading 2Dec21: Nine Volt

I don’t know what’s going on anymore, but I certainly can recognize bargain-bin gems when they appear. This is nuts: Viant (DSP): $598M Perion (PERI): $840M Magnite (MGNI): $2.33B DoubleVerify (DV): $4.92B “Open your mouth wide, a universal sigh.” –Bloom, Radiohead

Once more we are up against another COVID variant with Omicron and this time it looks like a real doozy given that countries are already restricting travel. As a result, Wall Street got sucker punched on Friday during shortened hours… but not for COVID vaccine makers, including Moderna (which jumped over 20%). Moderna (MRNA) has… Continue reading 29Nov21: Moderna vs. Omicron

Any follower of this blog knows that I don’t advise messing around with put or call options, as it’s better to be outright owners of shares versus borrowing shares to guess whether a stock will go up or down in one months time. Plus option traders can lose their shirts pretty quickly. With that said,… Continue reading 18Nov21: Options Expiry Angina

When choosing a single security is too difficult, sometimes it’s best to select the top companies within a field and create your own mini ETF. In the world of programmatic advertising there are six companies right now that are either the leaders or are so undervalued they’ve entered the zone of extreme value play (and… Continue reading 9Nov21: Prg’matic 6 Pack

The Dirty Dozen group of securities was created on October 7th and I’ll be tracking its progress by posting updates on the 7th of each month. Market cap will be the measurement for gains and losses. One month returns: Puma Biotech (PBYI) $164M (-36%) Brightcove (BCOV) $412M (-14%) Sierra Wireless (SWIR) $610M (4%) Shift Technologies… Continue reading 7Nov21: DD Report, Mo.1